Expert Opinion on Pharmacotherapy logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 2, Number 3, March 2001

< previous issue | all issues | next issue >

Miscellany

Pricing, profits and pharmacoeconomics - for whose benefit?
pp. 377-383(7)
Authors: Adams, J.R.; Ali, S.; Bennett, C.L.

Review article

Current treatment practice for essential thrombocythaemia in adults
pp. 385-393(9)
Authors: Griesshammer, M.; Bangerter, M.; Grünewald, M.

Anti-angiogenic therapy of proliferative diabetic retinopathy
pp. 395-407(13)
Authors: Danis, R.P.; Ciulla, T.A.; Criswell, M.; Pratt, L.

The pharmacology of methotrexate
pp. 409-417(9)
Authors: Barnhart, K.; Coutifaris, C.; Esposito, M.

Lipids and atherosclerosis: clinical management of hypercholesterolaemia
pp. 419-430(12)
Authors: Chin-Dusting, J.P.; Shaw, J.A.

Clinical management of protein C deficiency
pp. 431-439(9)
Author: Pescatore, S.L.

Antileukotrienes in asthma: present situation
pp. 441-466(26)
Authors: García-Marcos, L.; Schuster, A.

Miscellany

Rosiglitazone
pp. 467-478(12)
Authors: Wolffenbuttel, B.H.; Sels, J-P.; Huijberts, M.S.

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues
pp. 491-505(15)
Authors: Arun, B.; Frenkel, E.P.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page